Literature DB >> 28617703

Using Self-reports or Claims to Assess Disease Prevalence: It's Complicated.

Patricia St Clair1, Étienne Gaudette, Henu Zhao, Bryan Tysinger, Roxanna Seyedin, Dana P Goldman.   

Abstract

BACKGROUND: Two common ways of measuring disease prevalence include: (1) using self-reported disease diagnosis from survey responses; and (2) using disease-specific diagnosis codes found in administrative data. Because they do not suffer from self-report biases, claims are often assumed to be more objective. However, it is not clear that claims always produce better prevalence estimates.
OBJECTIVE: Conduct an assessment of discrepancies between self-report and claims-based measures for 2 diseases in the US elderly to investigate definition, selection, and measurement error issues which may help explain divergence between claims and self-report estimates of prevalence. DATA: Self-reported data from 3 sources are included: the Health and Retirement Study, the Medicare Current Beneficiary Survey, and the National Health and Nutrition Examination Survey. Claims-based disease measurements are provided from Medicare claims linked to Health and Retirement Study and Medicare Current Beneficiary Survey participants, comprehensive claims data from a 20% random sample of Medicare enrollees, and private health insurance claims from Humana Inc.
METHODS: Prevalence of diagnosed disease in the US elderly are computed and compared across sources. Two medical conditions are considered: diabetes and heart attack.
RESULTS: Comparisons of diagnosed diabetes and heart attack prevalence show similar trends by source, but claims differ from self-reports with regard to levels. Selection into insurance plans, disease definitions, and the reference period used by algorithms are identified as sources contributing to differences.
CONCLUSIONS: Claims and self-reports both have strengths and weaknesses, which researchers need to consider when interpreting estimates of prevalence from these 2 sources.

Entities:  

Mesh:

Year:  2017        PMID: 28617703      PMCID: PMC5507726          DOI: 10.1097/MLR.0000000000000753

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  19 in total

1.  Agreement between self-reported information and medical claims data on diagnosed diabetes in Oregon's Medicaid population.

Authors:  Duyen L Ngo; Lynn M Marshall; Richard N Howard; Jennifer A Woodward; Karen Southwick; Katrina Hedberg
Journal:  J Public Health Manag Pract       Date:  2003 Nov-Dec

2.  Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions.

Authors:  Thomas S Rector; Steven L Wickstrom; Mona Shah; N Thomas Greeenlee; Paula Rheault; Jeannette Rogowski; Vicki Freedman; John Adams; José J Escarce
Journal:  Health Serv Res       Date:  2004-12       Impact factor: 3.402

3.  Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients.

Authors:  Carrie N Klabunde; Linda C Harlan; Joan L Warren
Journal:  Med Care       Date:  2006-10       Impact factor: 2.983

4.  Hospital episodes and physician visits: the concordance between self-reports and medicare claims.

Authors:  Fredric D Wolinsky; Thomas R Miller; Hyonggin An; John F Geweke; Robert B Wallace; Kara B Wright; Elizabeth A Chrischilles; Li Liu; Claire B Pavlik; Elizabeth A Cook; Robert L Ohsfeldt; Kelly K Richardson; Gary E Rosenthal
Journal:  Med Care       Date:  2007-04       Impact factor: 2.983

5.  Identification of dementia: agreement among national survey data, medicare claims, and death certificates.

Authors:  Truls Ostbye; Donald H Taylor; Elizabeth C Clipp; Lynn Van Scoyoc; Brenda L Plassman
Journal:  Health Serv Res       Date:  2008-02       Impact factor: 3.402

6.  Accuracy of Medicare expenditures in the medical expenditure panel survey.

Authors:  Samuel H Zuvekas; Gary L Olin
Journal:  Inquiry       Date:  2009       Impact factor: 1.730

7.  Identifying chronic conditions in Medicare claims data: evaluating the Chronic Condition Data Warehouse algorithm.

Authors:  Yelena Gorina; Ellen A Kramarow
Journal:  Health Serv Res       Date:  2011-06-07       Impact factor: 3.402

8.  Validity of gout diagnoses in administrative data.

Authors:  Leslie R Harrold; Kenneth G Saag; Robert A Yood; Ted R Mikuls; Susan E Andrade; Hassan Fouayzi; Judith Davis; K Arnold Chan; Marsha A Raebel; Ann Von Worley; Richard Platt
Journal:  Arthritis Rheum       Date:  2007-02-15

9.  Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes.

Authors:  Elizabeth F O Kern; Miriam Maney; Donald R Miller; Chin-Lin Tseng; Anjali Tiwari; Mangala Rajan; David Aron; Leonard Pogach
Journal:  Health Serv Res       Date:  2006-04       Impact factor: 3.402

10.  The accuracy of medicare claims data in identifying Alzheimer's disease.

Authors:  Donald H Taylor; Gerda G Fillenbaum; Michael E Ezell
Journal:  J Clin Epidemiol       Date:  2002-09       Impact factor: 6.437

View more
  16 in total

1.  Sex, Race, and Age Differences in Prevalence of Dementia in Medicare Claims and Survey Data.

Authors:  Yingying Zhu; Yi Chen; Eileen M Crimmins; Julie M Zissimopoulos
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2021-02-17       Impact factor: 4.077

2.  Comparing ascertainment of chronic condition status with problem lists versus encounter diagnoses from electronic health records.

Authors:  Robert W Voss; Teresa D Schmidt; Nicole Weiskopf; Miguel Marino; David A Dorr; Nathalie Huguet; Nate Warren; Steele Valenzuela; Jean O'Malley; Ana R Quiñones
Journal:  J Am Med Inform Assoc       Date:  2022-04-13       Impact factor: 4.497

3.  Prevalence of eczema among adults in the United States: a cross-sectional study in the All of Us research program.

Authors:  Audrey C Leasure; Jeffrey M Cohen
Journal:  Arch Dermatol Res       Date:  2022-02-11       Impact factor: 3.017

4.  Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.

Authors:  Reza Mohebi; Chen Chen; Nasrien E Ibrahim; Cian P McCarthy; Hanna K Gaggin; Daniel E Singer; Emily P Hyle; Jason H Wasfy; James L Januzzi
Journal:  J Am Coll Cardiol       Date:  2022-08-09       Impact factor: 27.203

5.  US women screen at low rates for both cervical and colorectal cancers than a single cancer: a cross-sectional population-based observational study.

Authors:  Diane M Harper; Melissa Plegue; Masahito Jimbo; Sherri Sheinfeld Gorin; Ananda Sen
Journal:  Elife       Date:  2022-06-28       Impact factor: 8.713

6.  Lifetime Burden of Adult Congenital Heart Disease in the USA Using a Microsimulation Model.

Authors:  Cynthia L Gong; Henu Zhao; Yifan Wei; Bryan Tysinger; Dana P Goldman; Roberta G Williams
Journal:  Pediatr Cardiol       Date:  2020-07-10       Impact factor: 1.655

7.  Comparison of prevalence and exposure-disease associations using self-report and hospitalization data among enrollees of the world trade center health registry.

Authors:  Howard E Alper; Jennifer Brite; James E Cone; Robert M Brackbill
Journal:  BMC Med Res Methodol       Date:  2021-08-10       Impact factor: 4.615

8.  Rates and Predictors of Patient Underreporting of Hospitalizations During Follow-Up After Acute Myocardial Infarction: An Assessment From the TRIUMPH Study.

Authors:  César Caraballo; Rohan Khera; Philip G Jones; Carole Decker; Wade Schulz; John A Spertus; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-06-19

9.  Obesity-related multimorbidity and risk of cardiovascular disease in the middle-aged population in the United States.

Authors:  Lisa M Pollack; Mei Wang; Man Yee Mallory Leung; Graham Colditz; Cynthia Herrick; Su-Hsin Chang
Journal:  Prev Med       Date:  2020-08-05       Impact factor: 4.018

10.  Racial/Ethnic and Educational Disparities in the Impact of Diabetes on Population Health Among the U.S.-Born Population.

Authors:  Emma Zang; Scott M Lynch; Chen Liu; Nancy Lu; Julia Banas
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-08-11       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.